Australia markets closed

NeuroScientific Biopharmaceuticals Limited (NSB.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0450+0.0020 (+4.65%)
At close: 02:47PM AEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Cash flows from investing activities
Investments in property, plant and equipment
-2.382
-
-3.866
-29.878
-2.382
-19.079
Net cash used for investing activities
-2.382
-
-3.866
-29.878
-2.382
-19.079
Cash flows from financing activities
Common stock issued
-
-
-
13,507
960.798
5,932
Net cash used provided by (used for) financing activities
-
-
-
13,507
960.798
5,932
Net change in cash
10.488
-2,304
-6,946
10,875
-1,323
-
Cash at beginning of period
3,326
7,216
14,162
3,287
4,610
-
Cash at end of period
3,336
4,912
7,216
14,162
3,287
-
Free cash flow
Capital expenditure
-2.382
-
-3.866
-29.878
-2.382
-19.079
Free cash flow
10.488
-2,304
-6,946
-2,631
-2,284
-